Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Halozyme Therapeutics

Biotech & Life Sciences · San Diego, United States · Founded 1998 · IPO 2004 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$9.47B
Market cap · Apr/2026
Revenue
$1.40B
Latest reported FY

Investors

1 investor on Halozyme Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage

Global footprint

Where Halozyme Therapeutics has talent and traffic

Web traffic by country
11K monthly visits
across markets
🇺🇸 United States51.8%
🇬🇧 United Kingdom20%
🇪🇸 Spain17.3%
🇨🇦 Canada10%
🇮🇳 India1.8%
Top 5 markets shown

See Halozyme Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.